Caris Life Sciences Launches Caris MI Clarity, the First and Only AI-Powered Test to Predict Both Early and Late Distant Recurrence Risk in Breast Cancer at the Time of Diagnosis

. WEBINAR ANNOUNCEMENT  Bench-to-Bedside Transition of Novel HALO® and HALO AI Assays into Clinical Trials with HALO AP September 30, 2020 8:00 PDT | 11:00 EDT | 16:00 BST Transitioning novel assays underpinned by quantitative...

MOTIC LAUNCHES MOTICFLOW TELEPATHOLOGY PLATFORM To Enable Remote Case-Sharing and Consultations Global optics and digital pathology company Motic makes its workflow solution MoticFlow internationally available to help overcome travel...

Interview with Dr. Robert Mozayeni, Director of the Foundation for the Study of Inflammatory Disease in the United States Where do you work and what is your role there? I am a physician and researcher in Bethesda, Maryland, where I am a...

15 September 2020 7:00 PDT | 10:00 EDT | 15:00 BST In this webinar, you’ll learn about the importance of multiplex biomarker analysis including how advances in multiplexed immunofluorescent imaging and analysis can reveal biological and...

A Carefully Designed Solution Through global engineering collaborations at Leica Microsystems and Leica Biosystems, engineers designed a novel high-performance objective specifically designed to maximize field of view for high speed digital...

Visiopharm®, the Denmark-based leader in artificial intelligence-driven image analysis, tissue mining, and precision pathology, has been granted patents in the US and Europe for an AI and image analysis based approach to quantifying staining...